Timothy Illidge, BSc PhD FRCP FRCR FRCPath FMedSci

Search results

• 2017

  PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

  Faivre-Finn, C., Kordbacheh, T., Chan, C., Bossons, A., Franks, K., McDonald, F., Forster, M., Mendes, R., Quezada, S., Dovedi, S., Ralph, C., Popat, S., Harrington, K., Melcher, A., Popple, A. & Illidge, T., Jan 2017, p. S75(164).

  Research output: Contribution to conference › Abstract › peer-review

• PD-RAD: A translational study investigating PD-L1 expression after radiotherapy for non-small cell lung cancer (NSCLC)

  Kordbacheh , T., Chan , C., Faivre-Finn, C., Franks , K., McDonald , F., Forster , M., Mendes , R., Quezada , S., Dovedi , S., Ralph , C., Popat , S., Harrington , K., Melcher , A., Popple , A. & Illidge, T., Jan 2017, p. S78(168).

  Research output: Contribution to conference › Abstract › peer-review